NeoAMR Observational Study in Neonatal Sepsis

Status Completed

Clinical Trial Summary

Prospective, multinational, multicentre, observational cohort study of neonatal sepsis in partner institutions. The cohort study will be designed to evaluate health care utilization and current clinical practice and to assess risk factors for and outcomes of babies with neonatal sepsis (culture-negative and culture-positive).

Clinical Trial Description

1. NeoSEPSIS: Consecutive hospitalized babies with neonatal sepsis will be recruited and followed up until discharge from hospital or death (for a maximum of 28 days). A minimal neonatal sepsis dataset will determine (i) clinical presentations, associated features and risk factors (for example prematurity, SGA (small for gestational age)), (ii) rates of culture-positivity among babies with sepsis, (iii) current empirical treatment approaches (antimicrobials selected, dose, etc) (iv) outcomes of sepsis, including death, need for intensive care interventions and recurrence of sepsis during the follow-up period. Microbiological samples will be taken from sterile sites, blood and CSF, as clinically indicated and will be processed locally.

2. NeoBSI: Consecutive babies with positive blood/CSF cultures and sepsis will be recruited. Patient inclusion will be based on identification of relevant specified bacteria from blood / CSF cultures. In addition to the data collected for NeoSEPSIS, information will be collected on the isolates and their antimicrobial susceptibility patterns. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03721302
Study type	Observational
Source	Drugs for Neglected Diseases
Contact
Status	Completed
Phase
Start date	August 16, 2018
Completion date	February 29, 2020

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05692128` - Frequency and Severity of Thrombocytopenia in Neonatal Sepsis
Completed	`NCT00942084` - A Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants (PTN_Acyclo)	Phase 1
Completed	`NCT06002295` - A Comparative Analysis of 4% Chlorhexidine Versus Methylated Spirit as Prophylaxis of Omphalitis and Sepsis in Newborns	Phase 2
Not yet recruiting	`NCT05114057` - Use of NGAL for Fluid Dosing and CRRT Initiation in Pediatric and Neonatal AKI	N/A
Recruiting	`NCT04528251` - Comparison of the Effectiveness of Two Different Antibiotic Regimens of the Treatment of Pregnant Women With Preterm Rupture of Membranes
Active, not recruiting	`NCT03871491` - Azithromycin-Prevention in Labor Use Study (A-PLUS)	Phase 3
Completed	`NCT03746743` - Severity Index of Neonatal Septicemia Using Score for Neonatal Acute Physiology (SNAP) II
Completed	`NCT02386592` - Prevention of Nosocomial Bacteremia Among Zambian Neonates	N/A
Not yet recruiting	`NCT06113653` - Outcomes and Predictors of Mortality Among Preterm Infants With Neonatal Sepsis
Completed	`NCT03199547` - Pre-delivery Administration of Azithromycin to Prevent Neonatal Sepsis & Death	Phase 3
Completed	`NCT02147327` - Effects of Cord Blood 25-hydroxy-vitamin D Level on Early Neonatal Morbidities	N/A
Completed	`NCT01005589` - CD64 Measurement in Neonatal Infection and Necrotising Enterocolitis	N/A
Completed	`NCT00866567` - Defects in Opsonophagocytosis in Premature Infants	N/A
Completed	`NCT02281890` - Neurodevelopmental Outcomes After Suspected or Proven Sepsis: Secondary Analysis of INIS Trial Database	N/A
Suspended	`NCT05156333` - Probiotics and GBS Colonization in Pregnancy	N/A
Recruiting	`NCT05127070` - Evaluating the NeoTree in Malawi and Zimbabwe
Completed	`NCT03755635` - Neonatal Sepsis at Neonatal Intensive Care Units in Ghana	N/A
Completed	`NCT03247920` - Reduction of Intravenous Antibiotics In Neonates	Phase 4
Completed	`NCT03295162` - Effects of Melatonin as a Novel Antioxidant and Free Radicals Scavenger in Neonatal Sepsis	Phase 1/Phase 2
Completed	`NCT02954926` - Intravenous Immunoglobulin in Prevention of Preterm Neonatal Sepsis	Phase 3